Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Pfizer Inc
Pfizer Inc And Renovis Inc
Pfizer Inc Products Inc
Pfizer Inc Pfizer Products Inc
  

Pfizer Inc patents (2017 archive)

Recent patent applications related to Pfizer Inc. Pfizer Inc is listed as an Agent/Assignee. Note: Pfizer Inc may have other listings under different names/spellings. We're not affiliated with Pfizer Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Pfizer Inc-related inventors




Date Pfizer Inc patents (2017 archive) (updated weekly) - BOOKMARK this page
11/16/17Sulfonyl amide derivatives for the treatment of abnormal cell growth
11/09/17Enhanced stability of novel liquid compositions
11/02/17Interferon beta antibodies and uses thereof
11/02/17Engineered polypeptide conjugates and methods for making thereof using transglutaminase
10/26/17Sglt-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease
10/26/172-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
10/26/17N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl)-1,3-thiazol-4-yl] amides
10/26/17Treatment with anti-pcsk9 antibodies
10/19/17Substituted dihydroisoquinolinone compounds
10/05/17Bruton's tyrosine kinase inhibitors
09/28/17Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole
09/28/17Combination of a pd-1 antagonist and an alk inhibitor for treating cancer
09/28/172-thiopyrimidinones
09/28/17Benzenesulfonamides useful as sodium channel inhibitors
09/28/17Egfrviii specific chimeric antigen receptor for cancer immunotherapy
09/21/17Pemetrexed polymeric nanoparticles and methods of making and using same
09/21/17Methods of treating cancers with therapeutic nanoparticles
09/07/17Methods of use and combinations
08/31/17Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
08/31/17Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides
08/31/17Anti-il-7r antibody compositions
08/24/17Aminopyrimidinyl compounds
08/24/17Pyrazolo[1,5-a]pyrazin-4-yl derivatives
08/17/17Aryl and heteroaryl fused lactams
08/17/17Rorc2 inhibitors and methods of use thereof
08/17/17Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
08/10/17Therapeutic nanoparticles having egfr ligands and methods of making and using same
08/10/17Glycoconjugation processes and compositions
08/10/17Fgf23 fusion proteins
08/03/17Dual-ended lip balm container
08/03/17Dual-ended lip balm container
08/03/17Antibodies and antibody fragments for site-specific conjugation
08/03/17Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives
07/27/17Methods of controlling the morphology of polymeric nanoparticles
07/27/17Chimeric antigen receptors targeting epidermal growth factor receptor variant iii
07/27/17Antibodies specific for epidermal growth factor receptor variant iii and their uses
07/20/17Apixaban formulations
07/20/17Apixaban formulations
07/20/17Dosage forms of apixaban
07/20/17Cancer vaccines
07/20/17Pyrazolopyrimidine compounds
07/13/17Tropomyosin-related kinase inhibitors containing both a 1h-pyrazole and a pyrimidine moiety
07/06/17Stable formulations for lyophilizing therapeutic particles
07/06/17Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
06/29/17Rsv f protein mutants
06/29/17Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
06/29/17Cancer treatment
06/22/17Combination of a pd-1 antagonist and a 4-1bb agonist for treating cancer
06/15/17Heteroaromatic compounds and their use as dopamine d1 ligands
06/15/17Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of asgpr
06/15/17Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative diseases
06/15/17Combination of a pd-1 antagonist and a vegfr inhibitor for treating cancer
06/01/17Methods of treating cancers with therapeutic nanoparticles
06/01/172-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
06/01/17Site specific her2 antibody drug conjugates
06/01/17Benzamide and heterobenzamide compounds
06/01/17Methods of treating cancers with therapeutic nanoparticles
06/01/172-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
06/01/17Site specific her2 antibody drug conjugates
06/01/17Benzamide and heterobenzamide compounds
05/25/17Imidazopyridazine compounds
05/18/17Tissue-specific genome engineering using crispr-cas9
05/11/17Targeted therapeutic nanoparticles and methods of making and using same
05/04/17Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
04/27/17Anti-il-2 antibodies and compositions and uses thereof
04/20/17Method of cell culture
04/06/17Novel cyclopropabenzofuranyl pyridopyrazinediones
03/30/17N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides
03/30/17N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]oxazin-8a(8h)-yl)-thiazol-4-yl) amides
03/30/17N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl)-1,3-thiazol-4-yl]amides
03/30/17Combination of an anti-ccr4 antibody and a 4-1bb agonist for treating cancer
03/16/17Pyrazolopyridines and pyrazolopyrimidines
03/16/17Crystalline form of 6-[(4r)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl]isoquinoline-1-carbonitrile
03/16/17Novel imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as lrrk2 inhibitors
03/16/17Humanized antibodies
03/16/17Tissue factor pathway inhibitor antibodies and uses thereof
03/16/17Anti-efna4 antibody-drug conjugates
03/09/17Physiologically-relevant affinity measurements in vitro with backscattering interferometry
03/02/17Heteroaromatic compounds and their use as dopamine d1 ligands
02/23/17Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
02/23/17Cycloalkyl-linked diheterocycle derivatives
02/23/17Antibodies to madcam
02/16/17Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
02/16/17Antibody-drug conjugates with high drug loading
02/16/17Heterocyclic compounds and their use as dopamine d1 ligands
02/09/17Therapeutic polymeric nanoparticles comprising corticosteroids and methods of making and using same
02/09/17Heteroaromatic compounds and their use as dopamine d1 ligands
02/09/17Heteroaromatic compounds and their use as dopamine d1 ligands
02/02/171,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors
01/26/17Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
01/19/17Spliceostatin analogs and methos for their preparation
01/19/17Anti-notch3 antibodies and antibody-drug conjugates
01/19/17Pyrimidine derivatives
01/12/17Immunogenic glycoprotein conjugates
01/12/172-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides
01/05/17Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
01/05/17Sulfonyl amide derivatives for the treatment of abnormal cell growth







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Pfizer Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pfizer Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';